Can pinpointing a cognition-selective glycine transporter restore receptor function and reverse autism-related behaviors in adults? A new study identified the transporter SLC6A20 as a safe therapeutic target to reverse NMDA receptor (NMDAR) hypofunction.
Can pinpointing a cognition-selective glycine transporter restore receptor function and reverse autism-related behaviors in adults? A new study identified the transporter SLC6A20 as a safe therapeutic target to reverse NMDA receptor (NMDAR) hypofunction.
Share this Article
Recommended